Results 171 to 180 of about 114,162 (186)

Renalase, dopamine, and norepinephrine as markers for the development of hypertension in CKD patients. [PDF]

BMC Nephrol
Heryć R, Cecerska-Heryć E, Serwin N, Stodolak P, Goszka M, Polikowska A, Ciechanowski K, Wiśniewska M.   +7 more
europepmc   +1 more source

Typical Clinical Presentation of an Autosomal Dominant Polycystic Kidney Disease Patient with an Atypical Genetic Pattern. [PDF]

Genes (Basel)
Marzano N, Caprara C, Reis T, Montin DP, Pretto SM, Rigato M, Giuliani A, Gastaldon F, Mancini B, Ronco C, Zanella M, Zuccarello D, Corradi V.   +12 more
europepmc   +1 more source

Outcomes of Combined Liver-Kidney Transplantation in Polycystic Liver and Kidney Disease. [PDF]

Ann Transplant
Chen X, Lu Y, Wei L, Sun LY, Zeng Z, Qu W, Liu Y, Zhu Z.   +7 more
europepmc   +1 more source

Cost-Minimization Analysis of Tolvaptan Treatment for ADPKD in Southern Spain. [PDF]

Kidney Int Rep
Roca Oporto FJ, Espín J, Andrades Gómez C, Montilla Cosano G, Sánchez-Pozo MC, Rocha JL.   +5 more
europepmc   +1 more source

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial. [PDF]

BMJ Open
Bahlmann-Kroll E, Häckl S, Kramer S, Wulfmeyer VC, Glandorf J, Kaufeld J, Koch A, Hartung D, Schmidt BMW, Schmidt-Ott K, Schmitt R.   +10 more
europepmc   +1 more source

Treatment of emphysematous polycystic renal infection in patients with autosomal dominant polycystic kidney disease: Feasibility and limitations of percutaneous cyst drainage. [PDF]

Clin Nephrol Case Stud
Sugimoto H, Suwabe T, Kurihara S, Oba Y, Ikuma D, Mizuno H, Sekine A, Yamanouchi M, Miki K, Yokoyama T, Nakamura Y, Ishii Y, Wada T, Sawa N, Ubara Y.   +14 more
europepmc   +1 more source

Spot Versus 24-Hour Urine Osmolality Measurement in Autosomal Dominant Polycystic Kidney Disease: A Diagnostic Test Study. [PDF]

Kidney Med
Akbari A, Sriperumbuduri S, Mangalgi S, Joshi V, Sood M, Buh A, Biyani M, McCudden C, Hundemer GL, Brown PA.   +9 more
europepmc   +1 more source

Safety and efficacy of tolvaptan in real‑world Japanese patients with autosomal dominant polycystic kidney disease: final results of SLOW‑PKD surveillance. [PDF]

Clin Exp Nephrol
Mochizuki T, Muto S, Suzue K, Komaniwa S, Tanaka T, Fukuta Y, Yamashige Y.   +6 more
europepmc   +1 more source

Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience. [PDF]

Genes (Basel)
Rusu EE, Sorohan BM, Pandele R, Popescu A, Bobeica R, Balanica S, Zilisteanu DS, Iordache A, Lungu A, Ismail G.   +9 more
europepmc   +1 more source